40
DIABETES IN PREGNANCY DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Embed Size (px)

Citation preview

Page 1: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

DIABETES IN PREGNANCYDIABETES IN PREGNANCY

Josephine Carlos-Raboca, MD

Page 2: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

• Pregnancy is a time when Pregnancy is a time when serial metabolic changes serial metabolic changes in the mother are carefully in the mother are carefully regulated to provide regulated to provide optimum substrate to optimum substrate to mother and fetus. mother and fetus.

Page 3: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

GOALS:GOALS:

Normal outcome of index pregnancy.Decrease risk for abnormal glucose and

insulin homeostasis.Mother (before, during, after pregnancy).Infant subsequent generations.

Page 4: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Gestational Diabetes Mellitus Gestational Diabetes Mellitus (GDM)(GDM)

Any degree of glucose in tolerance with onset or first recognition during pregnancy.

4th International Workshop-Conference on GDM, 1998.

Page 5: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Pregestational Diabetes MellitusPregestational Diabetes Mellitus

Diabetes diagnosed before pregnancy.

Page 6: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

PrevalencePrevalence of GDMof GDM

1 – 14%USA--- 3-5%MMC (Asian Population)

– Raboca et al 13.4%

Page 7: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Perinatal Complications:Perinatal Complications:

MacrosomiaRespiratory Distress Syndrome (RDS)HypocalcemiaHyperbilirubinemiaHypoglycemiaPolycythemia

Page 8: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Congenital MalformationsCongenital Malformations

SkeletalCardiac (septal and outflow tract lesions)CNS and neural tube defectsGastrointestinal DefectsGenitourinary Tract lesions

Page 9: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Maternal and Fetal Factors of Maternal and Fetal Factors of TeratogenesisTeratogenesis

Genetic Background Teratological Period Disturbances in Maternal-Fetal Transport Concentrations of Metabolites Hyperglycemia Hyperketonemia Somatomedin inhibitors Arachidonic/myoinositol deficiency Generation of free oxygen radicals Genotoxity

Teratology 1997

Page 10: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Objectives:Objectives:

1. Recognize GDM

2. Know how to provide nutritional plan

3. Know how to give insulin

4. Discuss preconception and postpartum care

5. Recognize special problems of pregestational diabetes

Page 11: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Case ICase I

31 year old female

G1 PO, Age of Gestation 20 weeks

Weight gain of 5 kg in the last 4 weeks

BMI (pre-pregnant) = 30 Height: 165 cm actual body weight 90 kg Family History (+) DM in mother

Page 12: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

• Would you recommend Would you recommend testing for GDM at this testing for GDM at this time time or later at 24or later at 24thth to 28 to 28thth weeks of gestationweeks of gestation

Page 13: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Risk Factors of GDMRisk Factors of GDM

Age > 25 years of ageObesity – BMI > 27 kg/m2 or > 20% over

DBWFamily History of diabetes in first degree

relativeEthnicity (Hispanic American, Native

American, Asian American, Pacific Islander)

Page 14: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

ADA 2001ADA 2001

– Low risk – no test– Average risk – test at 24th-28th

week– High risk – test at 1st visit if

negative repeat at 24 – 28 weeks.

ASGODIP– Test at 1st visit and every

trimester if negative in previous test

Page 15: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

50 gm glucose challenge test was 150 mg/dl

100 gm OGTT F=102; 1H=192; 2H=155; 3H=140

Does this patient have GDM?

Page 16: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Diagnosis of GDMDiagnosis of GDM

100 gm OGTT 75 gm OGTT

mg/dl mml/L mg/dl mml/LF 95 5.3 95 5.3

1H 180 10.0 180 10.0

2H 155 8.6 155 8.6

3H 140 7.8

> 2 values met = GDM

ASGODIP, WHOEuropean Diabetes

Policy Group 1992-1998 75 gm OGTT, 2H >140

Page 17: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Prescribe diet for this patientPrescribe diet for this patientFor normal weight – 30 kcal/kg of

Present BWFor overweight – 24 kcal/kg of Present

BW For morbidly obese – 12 kcal/kg

Present BW3 meals, 3 snacks, 40% of total calories

= CHO Medical Management of Pregnancy

Complicated by Diabetes

Page 18: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

1. With diet, preprandial capillary blood glucose level were 70 - 80 mg/dl,2HPPCBG 95 – 115 mg/dl

2. Would she require insulin?

Page 19: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

ADA 2001ADA 2001

Insulin Required if diet fails to maintain glucose

at following levels. Fasting whole blood glucose < 95 mg/dl (5.3 mml/L) Fasting Plasma Glucose < 105 mg/dl (5.8 mml/L)

OR 1H Postprendial whole blood glucose < 140 mg/dl (7.8 mml/L) 1H Postprendial Plasma Glucose < 155 mg/dl (8.6 mml/L)

OR 2H Postprandial whole blood glucose < 120 mg/dl (6.7 mml/L) 2H Postprandial Plasma Glucose < 130mg/dl (7.2 mml/L)

Page 20: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

1. How would you follow up this patient Postpartum?

2. What are her chances of developing diabetes?

Page 21: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

75 gm OGTT > 6 wks. postpartum

FPG every year x 3 years

Page 22: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

50% in 20 years time50% in 20 years timePredictors of DMPredictors of DM

maternal obesity fasting hyperglycemia duration of time from

index pregnancy

Page 23: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

TRIPODTRIPOD

Page 24: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Case 2Case 2 28 years old Go Po

diabetic X 1 year

desires pregnancy

Page 25: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

When is the best time for

patient to get pregnant? What advise would you

give her?

Page 26: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Counseling about risk of malformation with poor control

Use of low dose estrogen progestogen

contraceptive till good metabolic control is

achieved.

Goals:

HBA is 1% above normal Preprandial CBG 70-110 mg/dl (3.9-5.6mml/L)

CPG 80-110 mg/dl (4.4-6.1 mml/L) 2H Postprandial CBG < 140 mg/dl (7.8mml/L)

CPG < 155 mg/dl (8.6mml/L)

Page 27: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

4-7 X / day4-7 X / day preprandial preprandial 1 hour or 2 hour post prandial 1 hour or 2 hour post prandial

Page 28: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

What other medical What other medical problems should you problems should you consider in a diabetic consider in a diabetic pregnant?pregnant?

Page 29: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Acceleration of retinopathy Pregnancy induced hypertension Progression of Nephropathy

Page 30: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

What is your goal for glycemic What is your goal for glycemic control during labor?control during labor?

Page 31: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

120 mg/dl D5 0.45 NSS at 100-125 ml/hour CBG every 1-4 hours Insulin infusion to start at

1unit/hour of regular insulin if CBG > 120 mg/dl

Page 32: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

THANK YOU.THANK YOU.

Page 33: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

HYPERGLYCEMIA AND HYPERGLYCEMIA AND ADVERSE PREGNANCY ADVERSE PREGNANCY

OUTCOME STUDY (HAPO)OUTCOME STUDY (HAPO)

Background: Overt diabetes clearly increases the risk of adverse pregnancy outcome

What level of glucose intolerance short of diabetes increases the risk of adverse pregnancy outcome?

Page 34: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Study protocolStudy protocol

75gm OGTT 24-32 weeks (average 28) 0,1,2 hours

Venous plasma, enzymatic methodResults provided if FPG> 105 (5.8)

2 hour > 200 (11.1)

any value <45(2.5)

otherwise blinded to caregivers

Page 35: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

EndpointsEndpoints

Relationship between maternal hyperglycemia and

cesarian rate

macrosomia rate

fetal hyperinsulinemia

neonatal obesity (skinfold thickness)

neonatal hypoglycemia rate

other morbidities

Page 36: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Study ProtocolStudy Protocol

Routine prenatal care Daily kick count from 28 weeks Random venous plasma glucose at 34-37 weeks if

> 160 mg/dl (8.9) or <45 Umbilical cord glucose and C-peptide levels Routine neonatal care Neonatal blood glucose at 1-2 hours of age First feeding 2 hours after birth (may nurse earlier

if desired)

Page 37: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Interim Study ReportInterim Study Report

Enrollment: 9396 womenDeliveries:5282

primary CS 14.5%

repeat CS 7.3%

prenatal loss 5.5/1000Number of OGTT: 7160Unblinded: 158 (2.2%)

Page 38: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Interim…Interim…

Glucose levels

FPG 10% > 90

1 hour 15% > 160

2 hour 4% > 140

Page 39: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

SummarySummary

Preliminary data from HAPO enrollees confirm the safety of the study protocol and yielded the predicted prevalence of “lesser degrees”of glucose intolerance that should permit an adequate test of the study hypothesis.

Page 40: DIABETES IN PREGNANCY Josephine Carlos-Raboca, MD

Study HypothesisStudy Hypothesis

Hyperglycemia in pregnancy less severe than overt diabetes is associated with increased risk of adverse maternal fetal and neonatal outcomes that is independently related to the degree of metabolic disturbance.